Relationship between plasma, atrial and ventricular perhexiline concentrations in humans: insights into factors affecting myocardial uptake

Nigel E Drury; Giovanni Licari; Cher-Rin Chong; Neil J Howell; Michael P Frenneaux; John D Horowitz; Domenico Pagano; Benedetta C Sallustio

doi:10.1111/bcp.12254

Relationship between plasma, atrial and ventricular perhexiline concentrations in humans: insights into factors affecting myocardial uptake

Nigel E Drury
, Giovanni Licari
, Cher-Rin Chong
, Neil J Howell
, Michael P Frenneaux
, John D Horowitz
, Domenico Pagano
, Benedetta C Sallustio

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

Abstract

Little is known regarding the steady-state uptake of drugs into the human myocardium. Perhexiline is a prophylactic anti-anginal drug which is increasingly also used in the treatment of heart failure and hypertrophic cardiomyopathy. We explored the relationship between plasma perhexiline concentrations and its uptake into the myocardium.

Original language	English
Pages (from-to)	789-95
Number of pages	7
Journal	British Journal of Clinical Pharmacology
Volume	77
Issue number	5
DOIs	https://doi.org/10.1111/bcp.12254
Publication status	Published - May 2014

Keywords

Age Factors
Aged
Biopsy
Double-Blind Method
Humans
Middle Aged
Myocardium
Perhexiline
Prospective Studies

Access to Document

10.1111/bcp.12254

Cite this

@article{7024d8c7623e4fda8f607ecdca47a038,

title = "Relationship between plasma, atrial and ventricular perhexiline concentrations in humans: insights into factors affecting myocardial uptake",

abstract = "Little is known regarding the steady-state uptake of drugs into the human myocardium. Perhexiline is a prophylactic anti-anginal drug which is increasingly also used in the treatment of heart failure and hypertrophic cardiomyopathy. We explored the relationship between plasma perhexiline concentrations and its uptake into the myocardium.",

keywords = "Age Factors, Aged, Biopsy, Double-Blind Method, Humans, Middle Aged, Myocardium, Perhexiline, Prospective Studies",

author = "Drury, \{Nigel E\} and Giovanni Licari and Cher-Rin Chong and Howell, \{Neil J\} and Frenneaux, \{Michael P\} and Horowitz, \{John D\} and Domenico Pagano and Sallustio, \{Benedetta C\}",

note = "{\textcopyright} 2013 The British Pharmacological Society.",

year = "2014",

month = may,

doi = "10.1111/bcp.12254",

language = "English",

volume = "77",

pages = "789--95",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley",

number = "5",

}

TY - JOUR

T1 - Relationship between plasma, atrial and ventricular perhexiline concentrations in humans

T2 - insights into factors affecting myocardial uptake

AU - Drury, Nigel E

AU - Licari, Giovanni

AU - Chong, Cher-Rin

AU - Howell, Neil J

AU - Frenneaux, Michael P

AU - Horowitz, John D

AU - Pagano, Domenico

AU - Sallustio, Benedetta C

PY - 2014/5

Y1 - 2014/5

N2 - Little is known regarding the steady-state uptake of drugs into the human myocardium. Perhexiline is a prophylactic anti-anginal drug which is increasingly also used in the treatment of heart failure and hypertrophic cardiomyopathy. We explored the relationship between plasma perhexiline concentrations and its uptake into the myocardium.

AB - Little is known regarding the steady-state uptake of drugs into the human myocardium. Perhexiline is a prophylactic anti-anginal drug which is increasingly also used in the treatment of heart failure and hypertrophic cardiomyopathy. We explored the relationship between plasma perhexiline concentrations and its uptake into the myocardium.

KW - Age Factors

KW - Aged

KW - Biopsy

KW - Double-Blind Method

KW - Humans

KW - Middle Aged

KW - Myocardium

KW - Perhexiline

KW - Prospective Studies

U2 - 10.1111/bcp.12254

DO - 10.1111/bcp.12254

M3 - Article

C2 - 24117487

SN - 0306-5251

VL - 77

SP - 789

EP - 795

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

IS - 5

ER -